Department of Ophthalmology, RWTH Aachen University, Aachen, Germany.
Cornea. 2010 Jan;29(1):113-6. doi: 10.1097/ICO.0b013e3181a06efa.
The purposes of this study are to report a case of adult-onset juvenile xanthogranuloma and suggest a new treatment option.
A 35-year-old man presented with an isolated mass of the limbus. Biopsy revealed a histiocytic tumor with Touton's giant cells staining positive for CD68 and S-100 but negative for CD1a, consistent with JXG. Two intratumoral injections of triamcinolone acetonide 6 weeks apart were performed. The main outcome measure was 6-months follow up clinically and by ultrasound biomicroscopy.
The lesion regressed, and corneal thickness returned to normal 3 months after the first injection. An increase in intraocular pressure required topical treatment. No recurrence was seen throughout follow up.
Limbal juvenile xanthogranuloma can be successfully treated with intralesional triamcinolone acetonide, thus avoiding a lamellar keratectomy approach.
本研究旨在报告一例成人发病型幼年黄色肉芽肿,并提出一种新的治疗选择。
一名 35 岁男性出现孤立性角膜缘肿块。活检显示为组织细胞肿瘤,Touton 巨细胞 CD68 和 S-100 染色阳性,而 CD1a 染色阴性,符合 JXG。6 周内分两次对肿瘤内注射曲安奈德,每次间隔 2 周。主要观察指标为 6 个月的临床和超声生物显微镜随访。
病变消退,第一次注射后 3 个月角膜厚度恢复正常。眼压升高需要局部治疗。随访期间未见复发。
角膜缘幼年黄色肉芽肿可以通过肿瘤内注射曲安奈德成功治疗,从而避免板层角膜切除术。